Combined use of galectin-3 and thyroid peroxidase improves the differential diagnosis of thyroid tumors
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F20%3A10405818" target="_blank" >RIV/00216208:11110/20:10405818 - isvavai.cz</a>
Alternative codes found
RIV/00064203:_____/20:10405818 RIV/00216208:11140/20:10405818 RIV/00669806:_____/20:10405818
Result on the web
<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=WXN_L4jhRm" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=WXN_L4jhRm</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.4149/neo_2019_190128N86" target="_blank" >10.4149/neo_2019_190128N86</a>
Alternative languages
Result language
angličtina
Original language name
Combined use of galectin-3 and thyroid peroxidase improves the differential diagnosis of thyroid tumors
Original language description
The study was focused on the assessment of an expression of galectin-3 and thyroid peroxidase (TPO) in a large collection of 186 thyroid tumors, benign and malignant and their oncocytic and non-oncocytic variants. Oncocytic tumors remain controversial with a respect to their pathobiology, behavior and management. The aim of this study was to evaluate the differential diagnostic/prognostic potential of both markers . In conclusion, the combined use of galectin-3 and TPO markers could help to improve the differential diagnosis of malignant thyroid tumors, whereas the use them as a single marker remains unsatisfactory. Differences in expression of both markers between oncocytic and non-oncocytic variants is another argument for an explanation of their differing pathobiology and their separation in independent neoplastic entities.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30206 - Otorhinolaryngology
Result continuities
Project
<a href="/en/project/GA18-03978S" target="_blank" >GA18-03978S: Effect of cell stiffness and microenvironment as a therapy response predictor in head and neck cancer</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2020
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Neoplasma
ISSN
0028-2685
e-ISSN
—
Volume of the periodical
67
Issue of the periodical within the volume
1
Country of publishing house
SK - SLOVAKIA
Number of pages
7
Pages from-to
164-170
UT code for WoS article
000542659200019
EID of the result in the Scopus database
2-s2.0-85078691434